Anna Spreafico, Khalil Sultanem, Jean-Pascal H. Machiels, Scott Victor Bratman, John Hilton, Lisa F. L. Licitra, Alexander V. Louie, Andrea McNiven, Jolie Ringash, Lillian L. Siu, John Waldron, Osama Souied, Andrew George Robinson, Changshu Wang, Craig Henry Harlos, Marc Oliva, John WT Walker, Kate Whelan, Wei Tu, Wendy R. Parulekar. "Final analysis of the investigator-initiated randomized study of anti–PD-L1 durvalumab (durva) with radiation versus chemoradiation (CRT) for intermediate-risk HPV-positive (HPV+) locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC): Canadian Cancer Trials Group (CCTG) HN.9 (EORTC 1740-HNCG).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6017